Kerkvliet NI - Search Results

1

Immune Cell Phenotyping Using Flow Cytometry.

Pockley AG, Foulds GA, Oughton JA, Kerkvliet NI, Multhoff G. Pockley AG, et al. Among authors: kerkvliet ni. Curr Protoc Toxicol. 2015 Nov 2;66:18.8.1-18.8.34. doi: 10.1002/0471140856.tx1808s66. Curr Protoc Toxicol. 2015. PMID: 26523471

2

Immune cell phenotyping using flow cytometry.

Oughton JA, Kerkvliet NI. Oughton JA, et al. Among authors: kerkvliet ni. Curr Protoc Toxicol. 2005;Chapter 18:Unit18.8. doi: 10.1002/0471140856.tx1808s23. Curr Protoc Toxicol. 2005. PMID: 23045120

3

Functional alterations in CD11b(+)Gr-1(+) cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Choi JY, Oughton JA, Kerkvliet NI. Choi JY, et al. Among authors: kerkvliet ni. Int Immunopharmacol. 2003 Apr;3(4):553-70. doi: 10.1016/S1567-5769(03)00046-8. Int Immunopharmacol. 2003. PMID: 12689660

4

Phenotypic analysis of spleen, thymus, and peripheral blood cells in aged C57B1/6 mice following long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Oughton JA, Pereira CB, DeKrey GK, Collier JM, Frank AA, Kerkvliet NI. Oughton JA, et al. Among authors: kerkvliet ni. Fundam Appl Toxicol. 1995 Apr;25(1):60-9. doi: 10.1006/faat.1995.1040. Fundam Appl Toxicol. 1995. PMID: 7601328

5

Anti-CD3-induced T-cell activation--II. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Neumann CM, Oughton JA, Kerkvliet NI. Neumann CM, et al. Among authors: kerkvliet ni. Int J Immunopharmacol. 1993 May;15(4):543-50. doi: 10.1016/0192-0561(93)90069-b. Int J Immunopharmacol. 1993. PMID: 8365828

6

Acute inflammatory response to sheep red blood cell challenge in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells.

Kerkvliet NI, Oughton JA. Kerkvliet NI, et al. Toxicol Appl Pharmacol. 1993 Apr;119(2):248-57. doi: 10.1006/taap.1993.1066. Toxicol Appl Pharmacol. 1993. PMID: 8480333

7

Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T-cell subsets and cytokine production.

Prell RA, Oughton JA, Kerkvliet NI. Prell RA, et al. Among authors: kerkvliet ni. Int J Immunopharmacol. 1995 Nov;17(11):951-61. doi: 10.1016/0192-0561(95)00080-1. Int J Immunopharmacol. 1995. PMID: 8788124

8

The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on tumor necrosis factor (TNF) production by peritoneal cells.

Moos AB, Oughton JA, Kerkvliet NI. Moos AB, et al. Among authors: kerkvliet ni. Toxicol Lett. 1997 Feb 7;90(2-3):145-53. doi: 10.1016/s0378-4274(96)03838-6. Toxicol Lett. 1997. PMID: 9067482

9

Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Kerkvliet NI, Baecher-Steppan L, Shepherd DM, Oughton JA, Vorderstrasse BA, DeKrey GK. Kerkvliet NI, et al. J Immunol. 1996 Sep 15;157(6):2310-9. J Immunol. 1996. PMID: 8805628

10

Novel phenotype associated with in vivo activated CTL precursors.

Oughton JA, Kerkvliet NI. Oughton JA, et al. Among authors: kerkvliet ni. Clin Immunol. 1999 Mar;90(3):323-33. doi: 10.1006/clim.1998.4673. Clin Immunol. 1999. PMID: 10075861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page